Please wait...
About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
More Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Can cattle ventilate effectively while tilted in a chute and receiving veterinary care?
Cattle are commonly presented to veterinarians for routine and emergent medical procedures. Lower limbs...
Can personalized medicine subtype bladder cancer?
Molecular pathoepidemiology is the study of the cause and natural history of disease on a molecular, individual...
MyHealthEd
Each child deserves quality comprehensive sexual health education. No child is the same, so why...